Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313–21. https://doi.org/10.1053/j.gastro.2016.10.020.
Jess T, Horvath-Puho E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: A Danish population-based cohort study. Am J Gastroenterol. 2013;108(12):1869–76. https://doi.org/10.1038/ajg.2013.249.
Article PubMed CAS Google Scholar
Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265–73. https://doi.org/10.1016/j.cgh.2013.03.034.
Hrabe JE, Byrn JC, Button AM, Zamba GK, Kapadia MR, Mezhir JJ. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome. J Surg Oncol. 2014;109(2):117–21. https://doi.org/10.1002/jso.23465.
Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: A Surveillance Epidemiology and End Results Medicare study. Dis Colon Rectum. 2012;55(3):270–7. https://doi.org/10.1097/DCR.0b013e318242620f.
Ording AG, Horváth-Puhó E, Erichsen R, et al. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn’s disease: a nationwide population-based cohort study. Inflamm Bowel Dis Mar-Apr. 2013;19(4):800–5. https://doi.org/10.1097/MIB.0b013e3182802af7.
Renz BW, Thasler WE, Preissler G, et al. Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis. J Gastrointest Surg. 2013;17(5):981–90. https://doi.org/10.1007/s11605-013-2171-z.
Noguchi T, Ishihara S, Uchino M, et al. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease. J Gastroenterol. 2023;58(1):14–24. https://doi.org/10.1007/s00535-022-01927-y.
Watanabe T, Konishi T, Kishimoto J, Kotake K, Muto T, Sugihara K. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17(3):802–8. https://doi.org/10.1002/ibd.21365.
Jensen AB, Larsen M, Gislum M, et al. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study. Am J Gastroenterol. 2006;101(6):1283–7. https://doi.org/10.1111/j.1572-0241.2006.00520.x.
Lin VA, Lohse R, Madsen MT, Fransgaard T, Remzi FH, Gögenur I. Long-term outcomes after colorectal surgery in patients with ulcerative colitis-associated colorectal cancer versus sporadic colorectal cancer. Ann Surg Oncol. 2022;29(4):2505–12. https://doi.org/10.1245/s10434-021-10759-8.
Leowardi C, Schneider ML, Hinz U, et al. Prognosis of ulcerative colitis-associated colorectal carcinoma compared to sporadic colorectal carcinoma: a matched pair analysis. Ann Surg Oncol. 2016;23(3):870–6. https://doi.org/10.1245/s10434-015-4915-3.
Han YD, Al Bandar MH, Dulskas A, et al. Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis. BMC Surg. 2017;17(1):28. https://doi.org/10.1186/s12893-017-0224-z.
Article PubMed PubMed Central Google Scholar
Shaukat A, Salfiti NI, Virnig DJ, et al. Is ulcerative colitis associated with survival among older persons with colorectal cancer in the US? A population-based case-control study. Dig Dis Sci. 2012;57(6):1647–51. https://doi.org/10.1007/s10620-011-1966-6.
Kuwabara H, Kimura H, Kunisaki R, et al. Postoperative complications, bowel function, and prognosis in restorative proctocolectomy for ulcerative colitis-a single-center observational study of 320 patients. Int J Colorectal Dis. 2022;37(3):563–72. https://doi.org/10.1007/s00384-021-04059-6.
Toritani K, Kimura H, Goto K, et al. Curable leakage in stapled IPAA has little effect on the long-term pouch function. Int J Colorectal Dis. 2023;38(1):43. https://doi.org/10.1007/s00384-023-04339-3.
Hashiguchi Y, Muro K, Saito Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1–42. https://doi.org/10.1007/s10147-019-01485-z.
Watanabe T, Muro K, Ajioka Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23(1):1–34. https://doi.org/10.1007/s10147-017-1101-6.
Watanabe T, Itabashi M, Shimada Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20(2):207–39. https://doi.org/10.1007/s10147-015-0801-z.
Article PubMed PubMed Central Google Scholar
Watanabe T, Itabashi M, Shimada Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17(1):1–29. https://doi.org/10.1007/s10147-011-0315-2.
Abdalla EK. Resection of colorectal liver metastases. J Gastrointest Surg. 2011;15(3):416–9. https://doi.org/10.1007/s11605-011-1429-6.
Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15(3):938–46. https://doi.org/10.1200/jco.1997.15.3.938.
Article PubMed CAS Google Scholar
Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324–38. https://doi.org/10.1016/j.athoracsur.2007.02.093.
Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17(12):1709–19. https://doi.org/10.1016/s1470-2045(16)30500-9.
Franko J. Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: surgeon’s perspective. Pleura Peritoneum. 2018;3(1):20180102. https://doi.org/10.1515/pp-2018-0102.
Article PubMed PubMed Central Google Scholar
Brentnall TA, Crispin DA, Bronner MP, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996;56(6):1237–40.
Watanabe T, Kobunai T, Toda E, et al. Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. Clin Cancer Res. 2007;13(2 Pt 1):415–20. https://doi.org/10.1158/1078-0432.Ccr-06-0753.
Article PubMed CAS Google Scholar
Yaeger R, Shah MA, Miller VA, et al. Genomic alterations observed in colitis-associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease. Gastroenterology. 2016;151(2):278-287.e6. https://doi.org/10.1053/j.gastro.2016.04.001.
Article PubMed CAS Google Scholar
Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011;140(6):1807–16. https://doi.org/10.1053/j.gastro.2011.01.057.
Article PubMed CAS Google Scholar
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–67. https://doi.org/10.1016/0092-8674(90)90186-i.
留言 (0)